DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target

Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.

Benzinga · 01/22/2020 12:02

Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.